216 related articles for article (PubMed ID: 30126180)
1. Relaxin 2/RXFP1 Signaling Induces Cell Invasion via the β-Catenin Pathway in Endometrial Cancer.
Fue M; Miki Y; Takagi K; Hashimoto C; Yaegashi N; Suzuki T; Ito K
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126180
[TBL] [Abstract][Full Text] [Related]
2. The role of relaxin in endometrial cancer.
Kamat AA; Feng S; Agoulnik IU; Kheradmand F; Bogatcheva NV; Coffey D; Sood AK; Agoulnik AI
Cancer Biol Ther; 2006 Jan; 5(1):71-7. PubMed ID: 16322684
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles for the relaxin/RXFP1 system in cancer therapy.
Thanasupawat T; Glogowska A; Nivedita-Krishnan S; Wilson B; Klonisch T; Hombach-Klonisch S
Mol Cell Endocrinol; 2019 May; 487():85-93. PubMed ID: 30763603
[TBL] [Abstract][Full Text] [Related]
4. Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-arrestin recruitment.
Callander GE; Thomas WG; Bathgate RA
Am J Physiol Cell Physiol; 2009 May; 296(5):C1058-66. PubMed ID: 19279230
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
6. Relaxin enhances the oncogenic potential of human thyroid carcinoma cells.
Hombach-Klonisch S; Bialek J; Trojanowicz B; Weber E; Holzhausen HJ; Silvertown JD; Summerlee AJ; Dralle H; Hoang-Vu C; Klonisch T
Am J Pathol; 2006 Aug; 169(2):617-32. PubMed ID: 16877360
[TBL] [Abstract][Full Text] [Related]
7. Altered relaxin family receptors RXFP1 and RXFP3 in the neocortex of depressed Alzheimer's disease patients.
Lee JH; Koh SQ; Guadagna S; Francis PT; Esiri MM; Chen CP; Wong PT; Dawe GS; Lai MK
Psychopharmacology (Berl); 2016 Feb; 233(4):591-8. PubMed ID: 26542729
[TBL] [Abstract][Full Text] [Related]
8. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
10. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
Ma J; Huang H; Han Z; Zhu C; Yue B
Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
[TBL] [Abstract][Full Text] [Related]
11. Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
Singh S; Bennett RG
Mol Cell Endocrinol; 2010 Feb; 315(1-2):239-45. PubMed ID: 19712722
[TBL] [Abstract][Full Text] [Related]
12. Profiling of relaxin and its receptor proteins in boar reproductive tissues and spermatozoa.
Feugang JM; Greene JM; Sanchez-Rodríguez HL; Stokes JV; Crenshaw MA; Willard ST; Ryan PL
Reprod Biol Endocrinol; 2015 May; 13():46. PubMed ID: 25990010
[TBL] [Abstract][Full Text] [Related]
13. Dual blockade of PKA and NF-κB inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis.
Vinall RL; Mahaffey CM; Davis RR; Luo Z; Gandour-Edwards R; Ghosh PM; Tepper CG; de Vere White RW
Horm Cancer; 2011 Aug; 2(4):224-38. PubMed ID: 21789713
[TBL] [Abstract][Full Text] [Related]
14. Using the novel HiBiT tag to label cell surface relaxin receptors for BRET proximity analysis.
Hoare BL; Kocan M; Bruell S; Scott DJ; Bathgate RAD
Pharmacol Res Perspect; 2019 Aug; 7(4):e00513. PubMed ID: 31384473
[TBL] [Abstract][Full Text] [Related]
15. MMP-2, TIMP-1, E-cadherin, and beta-catenin expression in endometrial serous carcinoma compared with low-grade endometrial endometrioid carcinoma and proliferative endometrium.
Shaco-Levy R; Sharabi S; Piura B; Sion-Vardy N
Acta Obstet Gynecol Scand; 2008; 87(8):868-74. PubMed ID: 18607832
[TBL] [Abstract][Full Text] [Related]
16. The relaxin family peptide receptor 1 (RXFP1): An emerging player in human health and disease.
Chen TY; Li X; Hung CH; Bahudhanapati H; Tan J; Kass DJ; Zhang Y
Mol Genet Genomic Med; 2020 Apr; 8(4):e1194. PubMed ID: 32100955
[TBL] [Abstract][Full Text] [Related]
17. The anti-fibrotic actions of relaxin are mediated through AT
Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
[TBL] [Abstract][Full Text] [Related]
18. The relaxin receptor as a therapeutic target - perspectives from evolution and drug targeting.
Bathgate RAD; Kocan M; Scott DJ; Hossain MA; Good SV; Yegorov S; Bogerd J; Gooley PR
Pharmacol Ther; 2018 Jul; 187():114-132. PubMed ID: 29458108
[TBL] [Abstract][Full Text] [Related]
19. Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cells.
Bialek J; Kunanuvat U; Hombach-Klonisch S; Spens A; Stetefeld J; Sunley K; Lippert D; Wilkins JA; Hoang-Vu C; Klonisch T
Mol Cancer Res; 2011 Jun; 9(6):673-87. PubMed ID: 21493587
[TBL] [Abstract][Full Text] [Related]
20. Relaxin family peptide receptors Rxfp1 and Rxfp2: mapping of the mRNA and protein distribution in the reproductive tract of the male rat.
Filonzi M; Cardoso LC; Pimenta MT; Queiróz DB; Avellar MC; Porto CS; Lazari MF
Reprod Biol Endocrinol; 2007 Jul; 5():29. PubMed ID: 17623071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
